FY2025 EPS Forecast for Vanda Pharmaceuticals Cut by Analyst
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2025 earnings estimates for shares of Vanda Pharmaceuticals in a report released on Thursday, May 8th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings of ($1.55) per share for the year, down from their […]
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Research analysts at Cantor Fitzgerald lowered their FY2025 earnings estimates for shares of Vanda Pharmaceuticals in a report released on Thursday, May 8th. Cantor Fitzgerald analyst C. Duncan now anticipates that the biopharmaceutical company will post earnings of ($1.55) per share for the year, down from their […]
